Intranasal convalescent plasma as prophylaxis against respiratory infections - Elise Wouters, Rode Kruis Vlaanderen

Intranasal convalescent plasma as prophylaxis against respiratory infections delivers antibody‑rich plasma directly to the upper respiratory mucosa to provide immediate, localized immune protection. This approach can be rapidly deployed, is low‑cost, and offers broad applicability in both epidemic and pandemic settings.